Skip to main content
FinSpry Logo
FinSpry
XFOR logo
XFOR
(NASDAQ)
X4 Pharmaceuticals, Inc.
$4.24-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

X4 Pharmaceuticals (XFOR) Stock Price & Financial Analysis

X4 Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$4.17 - $4.44
52-Week High$6.96
52-Week Low$1.35
Open$4.23
Volume206.09K
Average Volume (3M)206.09K
Market Cap183.48M
Shares Outstanding43.27M
Price to Sales (P/S)5.54
Price to Book (P/B)3.05
EV/EBITDA-2.32
Revenue (TTM)33.98M
Net Income (TTM)-95.09M
Free Cash Flow (TTM)-103.13M
EPS (TTM)$-2.20
Profit Margin-279.86%
Operating Margin-291.06%
Return on Equity (ROE)-154.33%
Debt to Equity1.25
50-Day MA$3.73
200-Day MA$3.27
52-Week Change-34.60%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About X4 Pharmaceuticals

What is the current stock price for XFOR?

As of the latest trading session, XFOR stock trades at $4.24. The 52-week range is $1.35–$6.96, with a day range of $4.17–$4.43.

What is the P/E ratio for XFOR?

The P/E ratio (Price-to-Earnings) for XFOR is shown in the Key Statistics section. This valuation metric helps compare X4 Pharmaceuticals, Inc. to industry peers.

Does XFOR pay dividends?

X4 Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for XFOR?

Based on 1 analyst, the consensus for XFOR is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of XFOR?

X4 Pharmaceuticals's market capitalization is $183.5M, classifying it as a micro-cap company. X4 Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.